HALISTER: Mylan Agrees to $465m Settlement Over EpiPen Medicaid Rebates

Mylan Agrees to $465m Settlement Over EpiPen Medicaid Rebates

(Bloomberg) -- Mylan agreed to $465m settlement with DOJ and other government agencies that will resolve questions about classification of EpiPen for the Medicaid Drug Rebate program.
  • NOTE: Oct. 6, Mylan Accused by U.S. of Overcharging Medicaid for EpiPen
Link to Statement:Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
MYL US (Mylan NV)

To de-activate this alert, click here

UUID: 7947283